APRE
Aprea Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.79
−1.49%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- $307.5K
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.07
- EPS estimate
- -$0.18
- Revenue actual
- —
- Revenue estimate
- $253.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -61.1%
- Revenue beats (12Q)
- 2
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026